// App-Quantinova.ai

3422 : The influence of genetic and clinical factors on the outcome following a diagnosis of small cell carcinoma of the ovary, hypercalcemic type

Researchers

Presenter

  • Leora Witkowski

Principal Investigators

  • Catherine Goudie

  • Pilar Ramos

  • Anthony N. Karnezis

  • Talia Boshari

  • Patricia Pautier

  • Michel Longy

  • James A. Knost

  • Emmanouil Saloustros

  • W Glenn McCluggage

  • Martin Hasselblatt

  • William P. Hendricks

  • David Huntsman

  • Douglas A. Levine

  • Jeffrey Trent

  • William D. Foulkes

Medical Centers

  • Montreal University, Montreal, QC, Canada

  • Translational Genomics Research Institute, Phoenix, AZ

  • BC Cancer Agency, Vancouver, British Columbia, Canada.

  • Lady Davis Institute, Montreal, Quebec, Canada

  • Gustave Roussy, Villejuif, France

  • Institut Bergonie, Bordeaux, France

  • Illinois CancerCare PC, Peoria, IL

  • University Hospital of Heraklion, Crete, Greece

  • Belfast Health and Social Care Trust, Belfast, United Kingdom

  • University Hospital of Muenster, Muenster, Germany

Locations

  • Canada

  • Greece

  • Germany

  • United Kingdom

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Solid malignancies

Biomarkers

  • SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 4

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A